BRISTOL MYERS SQUIBB CO
BMYAPI behind this page
BMY Q2 2025 request
Playground key active
/api/financials?ticker=BMY&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Abecma | 87 | 95 | -8.4% |
| Abraxane | 105 | 231 | -54.5% |
| Alliance and other revenues | 360 | 276 | +30.4% |
| Alliance revenues | 119 | 116 | +2.6% |
| Alliance revenues · Collaborative Arrangement | 119 | 116 | +2.6% |
| Breyanzi | 344 | 153 | +124.8% |
| Camzyos | 260 | 139 | +87.1% |
| Cobenfy | 35 | — | — |
| Eliquis | 3,680 | 3,416 | +7.7% |
| Gross product sales | 22,181 | 20,780 | +6.7% |
| Growth Portfolio | 6,596 | 5,596 | +17.9% |
| Krazati | 48 | 32 | +50.0% |
| Legacy Portfolio | 5,673 | 6,605 | -14.1% |
| Net product sales | 11,909 | 11,925 | -0.1% |
| Net product sales · Collaborative Arrangement | 3,720 | 3,470 | +7.2% |
| Opdivo | 2,560 | 2,387 | +7.2% |
| Opdivo Qvantig | 30 | — | — |
| Opdualag | 284 | 235 | +20.9% |
| Orencia | 963 | 948 | +1.6% |
| Other Growth products | 470 | 348 | +35.1% |
| Other Legacy products | 223 | 222 | +0.5% |
| Other revenues | 241 | 160 | +50.6% |
| Pomalyst/Imnovid | 708 | 959 | -26.2% |
| Reblozyl | 568 | 425 | +33.6% |
| Revlimid | 838 | 1,353 | -38.1% |
| Sotyktu | 70 | 53 | +32.1% |
| Sprycel | 120 | 424 | -71.7% |
| Yervoy | 728 | 630 | +15.6% |
| Zeposia | 150 | 151 | -0.7% |
Show Geography breakouts |
|||
| Non Us | 3,481 | 3,224 | +8.0% |
| Other | 270 | 176 | +53.4% |
| US | 8,519 | 8,801 | -3.2% |
Show — breakouts |
|||
| Revenue | 12,269 | 12,201 | +0.6% |
Show Type Of Arrangement breakouts |
|||
| Collaborative Arrangement | 3,840 | 3,586 | +7.1% |
| Cost of Revenue (Q) | — | — | — |
Show — breakouts |
|||
| Cost of Revenue | 3,372 | 3,267 | +3.2% |
Show Type Of Arrangement breakouts |
|||
| Collaborative Arrangement | 1,827 | 1,692 | +8.0% |
| Selling, General & Administrative (Q) | — | — | — |
Show — breakouts |
|||
| Selling, General & Administrative | 1,713 | 1,928 | -11.2% |
Show Type Of Arrangement breakouts |
|||
| Collaborative Arrangement | 68 | 65 | +4.6% |
| Research & Development (Q) | — | — | — |
Show — breakouts |
|||
| Research & Development | 2,580 | 2,899 | -11.0% |
Show Nature Of Expense breakouts |
|||
| Drug Development | 1,095 | 1,096 | -0.1% |
| Other | 1,195 | 1,467 | -18.5% |
| Research | 291 | 336 | -13.4% |
| Acquired I P R D (Q) | — | — | — |
Show — breakouts |
|||
| Acquired I P R D | 1,508 | 132 | +1042.4% |
| Amortizationof Acquired Intangible Assets (Q) | — | — | — |
Show — breakouts |
|||
| Amortizationof Acquired Intangible Assets | 830 | 2,416 | -65.6% |
| Other Non-Operating Income (Expense) (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Operating Income (Expense) | 494 | 273 | +81.0% |
Show Type Of Arrangement breakouts |
|||
| Collaborative Arrangement | -10 | -102 | +90.2% |
| Total Costs & Expenses (Q) | — | — | — |
Show — breakouts |
|||
| Total Costs & Expenses | 10,496 | 10,915 | -3.8% |
| Income Before Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Income Before Taxes | 1,773 | 1,286 | +37.9% |
| Income Tax Expense (Benefit) (Q) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 460 | -398 | +215.6% |
| Net Income (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 2 | 4 | -50.0% |
| Retained Earnings | 1,310 | 1,680 | -22.0% |
Show — breakouts |
|||
| Net Income | 1,313 | 1,684 | -22.0% |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | 2 | 4 | -50.0% |
| Net Income (Q) | — | — | — |
Show — breakouts |
|||
| Net Income | 1,310 | 1,680 | -22.0% |
| EPS (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 0.64 | 0.83 | -22.9% |
| EPS (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 0.64 | 0.83 | -22.9% |
| Interest Expense (Q) | — | — | — |
Show — breakouts |
|||
| Interest Expense | 485 | 521 | -6.9% |
| Interest Income (Q) | — | — | — |
Show — breakouts |
|||
| Interest Income | -139 | -87 | -59.8% |
| Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 1,181 | 1,624 | -27.3% |
| Wtd Avg Shares (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | 2,035 | 2,027 | +0.4% |
| Wtd Avg Shares (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 2,038 | 2,029 | +0.4% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -181 | 72 | -351.4% |
| Income Loss From Equity Method Investments (Q) | — | — | — |
Show — breakouts |
|||
| Income Loss From Equity Method Investments | 37 | -28 | +232.1% |
| Gain Loss On Investments (Q) | — | — | — |
Show — breakouts |
|||
| Gain Loss On Investments | 22 | -107 | +120.6% |
| Restructuring Settlement And Impairment Provisions (Q) | — | — | — |
Show — breakouts |
|||
| Restructuring Settlement And Impairment Provisions | 10 | — | — |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 12,599 | 6,293 | +100.2% |
| Available For Sale Securities Debt Securities Current (Q) | — | — | — |
Show — breakouts |
|||
| Available For Sale Securities Debt Securities Current | 1,004 | 360 | +178.9% |
| Receivables Net Current (Q) | — | — | — |
Show — breakouts |
|||
| Receivables Net Current | 11,415 | 11,423 | -0.1% |
Show Type Of Arrangement breakouts |
|||
| Collaborative Arrangement | 218 | 290 | -24.8% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 2,737 | 3,077 | -11.0% |
| Other Assets Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Assets Current | 5,466 | 5,737 | -4.7% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 33,222 | 26,890 | +23.5% |
| Accounts Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Receivable | 9,711 | 9,746 | -0.4% |
| Non-Current Assets | |||
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 7,373 | 6,845 | +7.7% |
| Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Goodwill | 21,776 | — | — |
| Deferred Tax Assets (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Assets | 4,647 | 3,323 | +39.8% |
| Available For Sale Securities Debt Securities Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Available For Sale Securities Debt Securities Noncurrent | 346 | 357 | -3.1% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 5,936 | 6,071 | -2.2% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 94,676 | 94,646 | 0.0% |
| Operating Lease Right-of-Use Assets (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Right-of-Use Assets | 1,276 | 1,316 | -3.0% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets Net Excluding Goodwill | 21,378 | 29,428 | -27.4% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Acquired marketed product rights | 11,773 | 18,747 | -37.2% |
| Computer Software Intangible Asset | 380 | 436 | -12.8% |
| Technology Based Intangible Assets | 1,540 | 1,870 | -17.6% |
Show Indefinite Lived Intangible Assets By Major Class breakouts |
|||
| In Process Research And Development | 7,685 | 8,375 | -8.2% |
| Current Liabilities | |||
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 4,715 | 3,531 | +33.5% |
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 5,427 | 3,751 | +44.7% |
Show Type Of Arrangement breakouts |
|||
| Collaborative Arrangement | 3,306 | 1,627 | +103.2% |
| Other Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Liabilities Current | 17,386 | 15,983 | +8.8% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 27,528 | 23,265 | +18.3% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Current Portion of Long-Term Debt | 4,475 | 3,092 | +44.7% |
| Non-Current Liabilities | |||
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 247 | 461 | -46.4% |
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 44,470 | 48,858 | -9.0% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 4,942 | 4,993 | -1.0% |
| Total Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities | 77,187 | 77,577 | -0.5% |
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 48,945 | 51,950 | -5.8% |
| Operating Lease Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Liabilities | 1,550 | 1,438 | +7.8% |
| Accrued Income Taxes Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Income Taxes Noncurrent | 1,438 | 1,783 | -19.3% |
| Stockholders' Equity | |||
| Common Stock Value Outstanding (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock Value Outstanding | 292 | 292 | 0.0% |
| Additional Paid-In Capital (Q) | — | — | — |
Show — breakouts |
|||
| Additional Paid-In Capital | 46,134 | 45,766 | +0.8% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -1,554 | -1,456 | -6.7% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 16,154 | 16,103 | +0.3% |
| Treasury Stock Common Value (Q) | — | — | — |
Show — breakouts |
|||
| Treasury Stock Common Value | -43,590 | — | — |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | 17,435 | — | — |
| Minority Interest (Q) | — | — | — |
Show — breakouts |
|||
| Minority Interest | 54 | 54 | 0.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -1,554 | -1,456 | -6.7% |
| Additional Paid In Capital | 46,134 | 45,766 | +0.8% |
| Common Stock | 292 | 292 | 0.0% |
| Noncontrolling Interest | 54 | 54 | 0.0% |
| Retained Earnings | 16,154 | 16,103 | +0.3% |
| Treasury Stock Common | -43,590 | -43,690 | +0.2% |
Show — breakouts |
|||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 17,489 | — | — |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 94,676 | 94,646 | 0.0% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (YTD) | — | — | — |
Show — breakouts |
|||
| Depreciation & Amortization | 2,023 | 5,128 | -60.5% |
| Deferred Income Taxes (YTD) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | -214 | -1,042 | +79.5% |
| Stock-Based Compensation (YTD) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 281 | 258 | +8.9% |
| Impairment Of Long Lived Assets To Be Disposed Of (YTD) | — | — | — |
Show — breakouts |
|||
| Impairment Of Long Lived Assets To Be Disposed Of | 318 | 871 | -63.5% |
| Divestituregainsandroyalties (YTD) | — | — | — |
Show — breakouts |
|||
| Divestituregainsandroyalties | -585 | -550 | -6.4% |
| Equity Method Investment Realized Gain Loss On Disposal (YTD) | — | — | — |
Show — breakouts |
|||
| Equity Method Investment Realized Gain Loss On Disposal | 100 | -209 | +147.8% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 (YTD) | — | — | — |
Show — breakouts |
|||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 336 | — | — |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 (Q) | — | — | — |
Show Contingent Consideration By Type breakouts |
|||
| Contingent value rights | 336 | — | — |
| Other Non-Cash Items (YTD) | — | — | — |
Show — breakouts |
|||
| Other Non-Cash Items | -2 | 20 | -110.0% |
| Increase Decrease In Receivables (YTD) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Receivables | -469 | -540 | +13.1% |
| Change in Inventory (YTD) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | -165 | -443 | +62.8% |
| Change in Accounts Payable (YTD) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Payable | -72 | 41 | -275.6% |
| Increase Decrease In Other Accrued Liabilities (YTD) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Other Accrued Liabilities | 254 | 70 | +262.9% |
| Increase Decrease In Accrued Income Taxes Payable (YTD) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accrued Income Taxes Payable | -567 | -1,033 | +45.1% |
| Increase Decrease In Other Operating Capital Net (YTD) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Other Operating Capital Net | -837 | -268 | -212.3% |
| Net Cash from Operations (YTD) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 5,871 | 5,160 | +13.8% |
| Investing Activities | |||
| Proceeds From Sale And Maturity Of Available For Sale Securities (YTD) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale And Maturity Of Available For Sale Securities | 744 | 822 | -9.5% |
| Payments To Acquire Marketable Securities (YTD) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Marketable Securities | -1,257 | -358 | -251.1% |
| Proceeds From Sale Of Equity Securities Fv Ni (YTD) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale Of Equity Securities Fv Ni | 12 | 60 | -80.0% |
| Capital Expenditures (YTD) | — | — | — |
Show — breakouts |
|||
| Capital Expenditures | -621 | -546 | -13.7% |
| Divestitureandotherproceeds (YTD) | — | — | — |
Show — breakouts |
|||
| Divestitureandotherproceeds | 513 | 511 | +0.4% |
| Payments To Acquire Businesses Net Of Cash Acquired (YTD) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Businesses Net Of Cash Acquired | -363 | -21,426 | +98.3% |
| Net Cash from Investing (YTD) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -972 | -20,937 | +95.4% |
| Financing Activities | |||
| Proceeds From Other Short Term Debt (YTD) | — | — | — |
Show — breakouts |
|||
| Proceeds From Other Short Term Debt | 426 | 409 | +4.2% |
| Repayments Of Long Term Debt (YTD) | — | — | — |
Show — breakouts |
|||
| Repayments Of Long Term Debt | -643 | -395 | -62.8% |
| Payments Of Dividends (YTD) | — | — | — |
Show — breakouts |
|||
| Payments Of Dividends | -2,520 | -2,429 | -3.7% |
| Payments For Proceeds From Stock Option Exercises And Other Adjustments (YTD) | — | — | — |
Show — breakouts |
|||
| Payments For Proceeds From Stock Option Exercises And Other Adjustments | -92 | -103 | +10.7% |
| Net Cash from Financing (YTD) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -2,829 | 10,621 | -126.6% |
| Supplemental | |||
| Income Taxes Paid (YTD) | — | — | — |
Show — breakouts |
|||
| Income Taxes Paid | 1.8 | 2.1 | -14.3% |
| Interest Paid (YTD) | — | — | — |
Show — breakouts |
|||
| Interest Paid | 1 | 735 | -99.9% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (YTD) | — | — | — |
Show — breakouts |
|||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 194 | -67 | +389.6% |
| Net Change in Cash (YTD) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | 2,264 | -5,223 | +143.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 12,611 | 6,296 | +100.3% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.